Sign in

CIK 0001761918

  • Emerging growth company

Erasca, Inc.

Sign in to watch
Ticker
ERAS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831217027
Phone
+1 858-465-6511
Business address
3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-04 Morris Shannon Chief Medical Officer Exercise or conversion 10b5-1 +20,000 $1.70 $34K 20,000
2026-03-04 Morris Shannon Chief Medical Officer Sale 10b5-1 −20,000 $15.04 $301K 0
2026-01-29 Morris Shannon Chief Medical Officer Grant or award · Stock option (right to buy) +625,000 625,000
2025-03-04 Morris Shannon Chief Medical Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −20,000 515,800
2025-02-03 Morris Shannon Chief Medical Officer Grant or award · Stock option (right to buy) +780,000 780,000
2024-06-20 Morris Shannon Chief Medical Officer Grant or award · Stock Option (right to buy) +137,142 137,142
2024-02-05 Morris Shannon Chief Medical Officer Grant or award · Stock Option (right to buy) +535,800 535,800
2023-04-10 Morris Shannon Chief Medical Officer Grant or award · Stock Option (Right to Buy) +375,000 375,000

Page 1 of 1 · 8 trades